The expression of chondroitin sulfate proteoglycan 4 (CSPG4) is decreased in BRAF-mutant induced drug-tolerant melanoma cells

Karolina Uranowska, Tanja Kalic, K Karapandza, Isabella Ellinger, Heimo Breiteneder, Helmut Schaider, Christine Hafner

Research output: Journal article (peer-reviewed) › Conference contribution to journal

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{78b8a61b311d4107a597c87c4d4f7ba6,

title = "The expression of chondroitin sulfate proteoglycan 4 (CSPG4) is decreased in BRAF-mutant induced drug-tolerant melanoma cells",

author = "Karolina Uranowska and Tanja Kalic and K Karapandza and Isabella Ellinger and Heimo Breiteneder and Helmut Schaider and Christine Hafner",

year = "2018",

language = "English",

volume = "27",

pages = "E80--E81",

journal = "Experimental Dermatology",

issn = "0906-6705",

publisher = "John Wiley and Sons Inc.",

number = "3",

}

TY - JOUR

T1 - The expression of chondroitin sulfate proteoglycan 4 (CSPG4) is decreased in BRAF-mutant induced drug-tolerant melanoma cells

AU - Uranowska, Karolina

AU - Kalic, Tanja

AU - Karapandza, K

AU - Ellinger, Isabella

AU - Breiteneder, Heimo

AU - Schaider, Helmut

AU - Hafner, Christine

PY - 2018

Y1 - 2018

M3 - Conference contribution to journal

SN - 0906-6705

VL - 27

SP - E80-E81

JO - Experimental Dermatology

JF - Experimental Dermatology

IS - 3

ER -